Leonard Mazur

Oncology

Leonard Mazur, CEO and Chairman of Citius Pharmaceuticals, discusses the launch of its first FDA-approved drug, Lymphir, for CTCL.

News

Lilly shrugs off concerns about the effect of US drug pricing policies on its diabetes and weight loss drugs as revenues leap 39% to $24.4bn.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.